Aims and scope

Epigenetics Communications covers the broad spectrum of epigenetic science from basic research to technological and therapeutic innovations, as well as their theoretical, ethical and societal dimensions. Epigenetics Communications is an innovative new, open-access journal devoted to the study and problematization of epigenetic principles and mechanisms in basic and translational research settings. It is also a forum for interdisciplinary debates around epigenetics, as well as for the investigation of its societal dimensions. In support of open science initiatives, the journal will have a level 4 data policy requiring data be made publicly available. The journal is divided into the following sections:
 

• Molecular Epigenetics (Histone Modifications; DNA Methylation; DNA Demethylation)
• Nuclear Organization
• Mitotic & Meiotic Heritability
• Epigenetic Drugs
• Epigenetic Technologies
• Epigenetic Bioengineering
• Network Epigenetics
• Computational Epigenomics
• Single Cell Epigenetics
• Epigenetic Toxicology
• Model Organisms (Vertebrates; Invertebrates; Plants; Unicellular systems)
• Epigenetics and Society

Epigenetics Communications will support the publication of manuscripts that contribute to a further understanding of epigenetic mechanisms that impact functioning of systems and organisms. Submissions describing clinical applications are referred to the sister journal, Clinical Epigenetics.

This new and innovative journal will also act as a forum to showcase and discuss alternative conclusions/interpretations of well-established epigenetic phenomena. These can be based either on the (re-)analyses of published and/or new data, or on the findings and results of epigenetic research in interaction with other disciplines. As such, we welcome 'systematic’ and ‘critical’ studies, be them positive (expected) or negative (non-expected) with respect to their outcomes.